254 related articles for article (PubMed ID: 7734353)
1. Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival.
Shepherd P; Suffolk R; Halsey J; Allan N
Br J Haematol; 1995 Mar; 89(3):546-54. PubMed ID: 7734353
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia.
Rozman C; Urbano-Ispizua A; Cervantes F; Rozman M; Colomer D; Féliz P; Pujades A; Vives Corrons JL
Leukemia; 1995 Jun; 9(6):1104-7. PubMed ID: 7596178
[TBL] [Abstract][Full Text] [Related]
3. Interferon response in chronic myeloid leukaemia correlates with ABL/BCR expression: a preliminary study.
Yin JL; Williams BG; Arthur CK; Ma DD
Br J Haematol; 1995 Mar; 89(3):539-45. PubMed ID: 7734352
[TBL] [Abstract][Full Text] [Related]
4. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic response to alpha-interferon is predicted in early chronic phase chronic myeloid leukemia by M-bcr breakpoint location.
Elliott SL; Taylor KM; Taylor DL; Rodwell RL; Williams BF; Shuttlewood MM; Wright SJ; Eliadis PE; Bunce IH; Frost TJ
Leukemia; 1995 Jun; 9(6):946-50. PubMed ID: 7596182
[TBL] [Abstract][Full Text] [Related]
6. Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemia.
Melo JV; Hochhaus A; Yan XH; Goldman JM
Br J Haematol; 1996 Mar; 92(3):684-6. PubMed ID: 8616036
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia.
Fioretos T; Nilsson PG; Aman P; Heim S; Kristoffersson U; Malm C; Simonsson B; Turesson I; Mitelman F
Leukemia; 1993 Aug; 7(8):1225-31. PubMed ID: 8350622
[TBL] [Abstract][Full Text] [Related]
8. Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts.
Sharma P; Kumar L; Mohanty S; Kochupillai V
Ann Hematol; 2010 Mar; 89(3):241-7. PubMed ID: 19714331
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating normal and BCR-ABL+Ve progenitor numbers in Philadelphia chromosome-positive acute myeloid leukaemia.
Baines P; Austin S; Fisher J; Owen-Jones E; Lee-Jones L; Throp D; Mckinley M; Hoy T; Mills K; Thompson P; Burnett A
Leuk Res; 2002 Nov; 26(11):997-1005. PubMed ID: 12363468
[TBL] [Abstract][Full Text] [Related]
10. Dual transcription of b2a2 and b3a2 BCR-ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene.
Branford S; Hughes TP; Rudzki Z
Br J Haematol; 2002 Jun; 117(4):875-7. PubMed ID: 12060123
[TBL] [Abstract][Full Text] [Related]
11. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
Prejzner W
Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Implication of BCR-ABL Fusion Transcript Variants in Chronic Myeloid Leukemia (CML) Treated with Imatinib. A First of Its Kind Study on CML Patients of Kashmir.
Azad NA; Shah ZA; Pandith AA; Khan MS; Rasool R; Rasool J; Aziz SA
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1479-1485. PubMed ID: 29936718
[TBL] [Abstract][Full Text] [Related]
13. Association of BCR/ABL transcript variants with different blood parameters and demographic features in Iraqi chronic myeloid leukemia patients.
Khazaal MS; Hamdan FB; Al-Mayah QS
Mol Genet Genomic Med; 2019 Aug; 7(8):e809. PubMed ID: 31206255
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of Bcr-abl type transcript and its relationship with platelet count in Mexican patients with chronic myeloid leukemia].
Rosas-Cabral A; Martínez-Mancilla M; Ayala-Sánchez M; Vela-Ojeda J; Bahena-Reséndiz P; Vadillo-Buenfil M; Aviña-Zubieta JA; Salazar-Exaire D; Miranda-Peralta E; Marroquín A; Longoria-Revilla E
Gac Med Mex; 2003; 139(6):553-9. PubMed ID: 14723051
[TBL] [Abstract][Full Text] [Related]
15. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.
van Rhee F; Hochhaus A; Lin F; Melo JV; Goldman JM; Cross NC
Blood; 1996 Jun; 87(12):5213-7. PubMed ID: 8652835
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia.
Bennour A; Ouahchi I; Achour B; Zaier M; Youssef YB; Khelif A; Saad A; Sennana H
Med Oncol; 2013 Mar; 30(1):348. PubMed ID: 23269583
[TBL] [Abstract][Full Text] [Related]
17. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
[TBL] [Abstract][Full Text] [Related]
18. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
[TBL] [Abstract][Full Text] [Related]
19. BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia.
Diamond J; Goldman JM; Melo JV
Blood; 1995 Apr; 85(8):2171-5. PubMed ID: 7718887
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India.
Anand MS; Varma N; Varma S; Rana KS; Malhotra P
Indian J Med Res; 2012; 135(1):42-8. PubMed ID: 22382182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
